The drug sorafenib attacks a genetic mutation active in about a third of patients with acute myeloid leukemia (AML).
“AML patients with this mutation
have a particularly poor prognosis, so this highly targeted drug appears to be a significant step forward in leukemia therapy,” said senior author Michael Andreeff of the University of Texas M. […]
No Comments »
Filed under:
The study, conducted in India on mice models, found that minocycline, an USFDA approved drug, often used to treat acne, reduces death rates by lowering
the microglial activation, neuronal death as well as viral replication.
The team found that Microglia are cells that act as the “cleanup crew” for the Central Nervous System (CNS). They […]
No Comments »
Filed under:
OCD is a psychiatric anxiety disorder most commonly characterized by a subject’s obsessive, distressing, intrusive thoughts and related compulsions (tasks
or “rituals”), which attempt to neutralize the obsessions.
The study, led by Dr. Ghulam Mustafa Soomro, honorary research fellow at St. George?s Hospital Medical School in London, stated that patients who take selective serotonin reuptake […]
No Comments »
Filed under:
“We are encouraging the new government of Thailand to continue” the programme, Oxfam’s regional director for East Asia, Sarah Ireland said at a news conference.
“We urge the government to listen to the poor people in Thailand,” she said.
Under the scheme, Thailand’s previous military government issued so-called compulsory licences, which temporarily suspend patent protections […]
No Comments »
Filed under:
Previous studies on cocaine addiction and efforts to block its addictiveness have focused on dopamine transporters, proteins that reabsorb the brain’s
?reward? chemical once its signal is sent.
Since the drug blocks dopamine transporters from doing their recycling job, it leaves the feel-good chemical around to keep sending the pleasure signal.
Now, the new study […]
No Comments »
Filed under:
Bayer said Phase III trials in patients with non-small cell lung cancer (NSCLC) had been stopped because Nexavar, already used to treat liver and some
kidney cancers, “would not meet its primary end-point of improved overall survival.”
Nexavar is one of the group’s best selling treatments, while NSCLC is the most common form of lung […]
No Comments »
Filed under:
It is to begin analysing pricing trends of 74 bulk drugs that come under the government-notified price-controlled list every quarter.
The authority’s
comparison will be based on three major parameters — the notified or approved prices of these bulk drugs, the landed cost of the imported bulk drugs and the prices quoted in the trade […]
No Comments »
Filed under:
Starting virtually from scratch, the pharmaceutical industry in India has over the last 30 years evolved into a world leader in producing high quality
drugs with the lowest cost of production, and now is ranked fourth globally in terms of volume and 13th in terms of value of production.
Despite having emerged as one of […]
No Comments »
Filed under:
There is already a drug on the market, Revia, which treats alcoholism by reducing the body’s ability to enjoy its effects.
This new drug cuts cravings
by taking the edge off of stressful situations which might push recovering alcoholics to pick up the bottle again.
Behavioral stress is a major factor in extending the ‘vicious […]
No Comments »
Filed under:
Artery-clogging lesions are a leading cause of heart attack and stroke and death worldwide.
Dr. Lisa Cassis and Dr. Alan Daugherty found the possible
added benefit of the new drug in animal studies.
‘In my many years of atherosclerosis research, this is one of the most striking effects I have seen on preventing the disease […]
No Comments »
Filed under: